Merck & Co., Inc.
MRK
$92.66
-$0.535-0.57%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 64.17B | 63.17B | 62.48B | 61.40B | 60.11B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 64.17B | 63.17B | 62.48B | 61.40B | 60.11B |
| Cost of Revenue | 14.70B | 14.79B | 15.13B | 15.44B | 15.92B |
| Gross Profit | 49.47B | 48.39B | 47.35B | 45.96B | 44.20B |
| SG&A Expenses | 10.10B | 10.05B | 9.85B | 9.84B | 9.88B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 40.75B | 45.75B | 43.33B | 43.39B | 43.66B |
| Operating Income | 23.42B | 17.43B | 19.15B | 18.01B | 16.45B |
| Income Before Tax | 19.94B | 13.72B | 15.25B | 3.91B | 1.89B |
| Income Tax Expenses | 2.80B | 1.56B | 1.50B | 1.59B | 1.51B |
| Earnings from Continuing Operations | 17.13K | 12.16K | 13.75K | 2.32K | 377.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -16.00M | -15.00M | -16.00M | -13.00M | -12.00M |
| Net Income | 17.12B | 12.15B | 13.74B | 2.31B | 365.00M |
| EBIT | 23.42B | 17.43B | 19.15B | 18.01B | 16.45B |
| EBITDA | 27.67B | 21.46B | 23.01B | 21.69B | 20.19B |
| EPS Basic | 6.75 | 4.79 | 5.42 | 0.91 | 0.14 |
| Normalized Basic EPS | 5.57 | 4.09 | 4.45 | 4.21 | 3.87 |
| EPS Diluted | 6.73 | 4.77 | 5.39 | 0.89 | 0.13 |
| Normalized Diluted EPS | 5.56 | 4.08 | 4.43 | 4.19 | 3.85 |
| Average Basic Shares Outstanding | 10.14B | 10.13B | 10.14B | 10.14B | 10.15B |
| Average Diluted Shares Outstanding | 10.17B | 10.16B | 10.17B | 10.16B | 10.17B |
| Dividend Per Share | 3.08 | 3.04 | 3.00 | 2.96 | 2.92 |
| Payout Ratio | 45.80% | 63.72% | 55.64% | 327.06% | 2,039.73% |
